Reconsidering sore throats - Part 1: Problems with current clinical practice

Canadian Family Physician

Volumn 43, Issue MAR., 1997, Pages 485-493

  McIsaac, Warren J ^a   Goel, Vivek ^b   Slaughter, Pamela M ^b   Parsons, G Wayne ^b   Woolnough, K V ^b   Weir, Paul T ^b   Ennet, Joseph R ^b  

^a Mt Sinai Family Medicine Centre   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; COST; DRUG USE; HUMAN; PHARYNGITIS; REVIEW; RHEUMATIC FEVER; SORE THROAT; STREPTOCOCCUS GROUP A;

ANTI-BACTERIAL AGENTS; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PHARYNGITIS; PHYSICIAN'S PRACTICE PATTERNS; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0030896859     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Weinkauf DJ, Rowland GC. Patient conditions at the primary care level: a commentary on resource allocation. Ont Med Rev 1992;59(1):11-5,61.
2. Ontario Ministry of Health. Office visits to physicians. Ten leading diagnoses January to March 1991. Toronto: Ontario Public Education Program on Health Care, Health Strategies Office, 1993.
3. Little PS, Williamson I. Are antibiotics appropriate for sore throats? Costs outweigh benefits. BMJ 1994;309:1010-1.
4. Shvartsman P. Are antibiotics appropriate for sore throats? Careful prescribing is beneficial. BMJ 1994;309:1011-2.
5. Quinn RW. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease and scarlet fever: the decline of rheumatic fever. Rev Infect Dis 1989; 11:928-53.
6. Rabkin SW, Chu-Chu-Lin SF. Epidemiology of valvular heart disease in Canada. Can J Cardiol 1988;4:412-6.
7. Stollerman GH. Variation in Group A streptococci and the prevalence of rheumatic fever: a half-century vigil. Ann Intern Med 1993;118:467-9.
8. Denny FW, Wannamaker LW, Brink WR, Rammel kamp CH Jr, Custer EA. Prevention of rheumatic fever treatment of the preceding streptococcic infection. JAMA 1950;143:151-3.
9. Brumfit W, O'Grady F, Slator JDH. Benign streptococcal sore throat. Lancet 1959;2:419-23.
10. Hutten-Czapaki P. Acute rheumatic fever - no epidemic in Ontario. Can J Public Health 1989;80:71-2.
11. Allen UD, Braudo M, Read SE. Acute rheumatic fever: findings of a hospital-based study and an overview of reported outbreaks. Can J Infect Dis 1990;1:77-81.
12. Kawakita S. Rheumatic fever and rheumatic heart disease in Japan. Jpn Circ J 1986;50:1241-5.
13. Yarrow A, Slater PE. The decline of acute rheumatic fever in Israel. Public Health Rev 1990;18:239-49.
14. Kaplan EL. Global assessment of rheumatic fever and rheumatic fever at the close of the century. Influences and dynamics of populations and pathogens: a failure to realize prevention? Circulation 1993;88(4 Pt 1):1964-72.
15. Longstaffe S, Postl B, Kao H, Nicolle L, Ferguson CA. Rheumatic fever in native children in Manitoba. Can Med Assoc J 1982;127:497-8.
16. Nielson G, Streetfield RW, West M, Johnson S, Glavin W, Baird S. Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, North Queensland. Establishment of a prophylactic program. Med J Aust 1993; 158:316-8.
17. Wallace MR, Garst PD, Papadimos TJ, Oldfield EC. The return of acute rheumatic fever in young adults. JAMA 1989;262:2557-61.
18. Veasy LG, Tani LY, Hill HR. Persistance of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1991;124:9-16.
19. Massell BF, Chute CG, Walker AM, Kurland GS. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988; 318:280-6.
20. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991;325:783-93.
21. American Academy of Pediatrics, Committee on Infectious Diseases. Report of the Committee on Infectious Diseases. 22nd ed. Elk Grove Village, 111: American Academy of Pediatrics, 1991.
22. Dajani AS, Bisno AL, Chung KJ, Durack DT, Gerber MA, Kaplan EL, et al. Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation 1988;78:1082-6.
23. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. 1. Factors related to the attack rate of rheumatic fever. N Engl J Med 1961;265:559-66.
24. Goslings WRO, Valkenburg HA, Bots AW, Lorrier JC. Attack rates of streptococcal pharyngitis, rheumatic fever and glomerulonephritis in the general population. I. A controlled pilot study of streptococcal pharyngitis in one village. N Engl J Med 1963;268:687-94.
25. Valkenburg HA, Haverkorn MJ, Goslings WRO, Lorrier JC, de Moor CE, Maxted WR. Streptococcal pharyngitis in the general population. II. The attack rate of rheumatic fever and acute glomerulonephritis in patients not treated with penicillin. J Infect Dis 1971;124:348-58.
26. Del Mar C. Managing sore throat: a literature review. II. Do antibiotics confer benefit? Med J Aust 1992;156:644-9.
27. Touw-otten F, Johansen KS. Diagnosis, antibiotic treatment and outcome of acute tonsillitis: report of a WHO regional office for Europe study in 17 European countries. Fam Pract 1992;9:255-62.
28. Nierenstein JH, Rogers KD. Streptococcal pharyngitis. Early treatment and management by nurse practitioners. JAMA 1974;227:1278-82.
29. Randolph MF, Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr 1985;106:870-4.
30. Middleton DB, D'Amico F, Nierenstein JH. Standardized symptomatic treatment versus penicillin as initial therapy for streptococcal pharyngitis. J Pediatr 1988;113:1089-94.